Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
8th grade Avg
|
|
New words:
AAD, abreast, abroad, Accolate, Acquistion, Acumen, aforesaid, ago, ALD, alert, alfa, allogeneic, AMNOG, Amoxil, anastrazole, anemia, antibacterial, apprised, Araku, arguing, arisen, Arixtra, asserted, AstraZeneca, attached, attaching, Augmentin, Banco, Banjara, banker, batch, benazapril, benazepril, besylate, bolivar, bond, bps, Bristol, CADIVI, capture, captured, chemotherapy, Chirotech, chlophenaramine, Circuit, clarification, classification, clocortolone, Cloderm, codeine, Colorado, compendia, context, Copenhagen, Coria, corrective, cough, Cresp, Cuernevaca, curb, CV, darbepoetin, debarment, decontamination, Deed, deployment, Detention, devaluation, devalue, device, Devunipalavalasa, Dialex, dinancial, disaggregation, dissolved, domperidone, DSR, duodenal, DWPE, emanating, encompassed, enlarged, epoetin, esomeprazole, explanatory, extrapolating, fondaparinux, forefront, frequency, fromall, Fuerte, gas, gastroesophageal, Gemeinsamer, greatly, greenhouse, groundwater, heart, heavy, Hongkong, hygiene, hyperinflationary, hypertension, IDBI, ImmuneDesign, inaccurate, incentivized, jnjection, Karlsruhe, kidney, KunshanRotam, Kyoto, Legacy, levocetirizine, levofloxacin, lifted, lingering, liver, Lynch, Macred, macroeconomic, Mandal, mandatorily, medium, merchandise, merchant, Merill, misleading, misuse, municipal, Narcotic, Nexium, nomination, Nordic, novelty, nurturing, official, ofNil, ordinarily, ornidazole, orphan, oxycontin, patentee, penicillin, peptic, perpetuity, Pharmacopeia, pivalate, pose, preexisting, preliminarily, Prevacid, Prograf, Protonix, PuraCap, Ranasthalam, recognised, reconstitute, reconstitution, reflux, repealing, retreat, revolving, rHuEPO, Road, rosuvastatin, Rozat, Rupanex, rupatidine, sanctioned, Sanofi, satisfaction, Senate, Shri, simpler, Singapore, soil, strictly, subdivision, successor, Supamove, Tennessee, thiocolchicoside, Toilet, traditional, training, trustee, Trusteeship, Tunisia, UCG, ulcer, understood, undertook, undrawn, unlawful, unpaid, Uruguay, Valeant, valuable, VEF, Venezuelan, voluntarily, warning, waszero, winning, withdrew, wrongfully, Xencor, Xyzal, zafirlukast, ZAR
Removed:
absorb, Ameerpet, Argenta, belonging, cancer, ceased, Chartered, clintec, collaborate, collaborated, Columbia, commissioned, consecutive, consultation, COPD, counter, differentiating, differentiation, diverse, empowering, encouraged, equally, exceeded, exhausted, expended, factor, fiduciary, filling, Forest, fulfilling, gave, guaranteed, Jamshedpur, Lek, Maryland, moved, obstructive, optimized, Ordinance, Padmashri, penalized, perspective, physician, Pliva, Prabir, preferably, preference, psychological, pulmonary, qualification, rebated, recourse, recovered, recruitment, rejected, renewed, roughly, Rs, selection, SmithKline, Spain, standing, Strategically, Sudan, switch, syndicated, syndication, Telecom, Thermax, title, topoisomerase, toxicology, travel, undergoing
Filing tables
Filing exhibits
RDY similar filings
Filing view
External links
EXHIBIT 99.4
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Dr. Reddy’s Laboratories Limited (the “Company”) on Form 20-F for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Umang Vohra, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Umang Vohra | ||||
| Umang Vohra | ||||
| Chief Financial Officer | ||||
Date: July 20, 2011
Hyderabad, India
Hyderabad, India